A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

NCT03149991 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Brexpiprazole
DRUG: Ketamine
DRUG: Placebo

Sponsor

Massachusetts General Hospital